MSR1 and atherosclerosis: They also competed with oxLDL uptake and downregulated the expression of primary scavenger receptors such as CD36 and macrophage scavenger receptor 1 (MSR1) to exert their atheroprotective effects for a site-directed treatment for atherosclerosis plaques.